BackBackTotal operating expenses of Zentalis Pharmaceuticals, Inc.
Annual data
−280.00 M
−210.00 M
−140.00 M
−70.00 M
0.00
Period
Value
Change
Change %
TTM
−249.83 M
+4.11 M
+1.62%
2023
−253.94 M
−26.65 M
−11.73%
2022
−227.29 M
−19.55 M
−9.41%
2021
−207.74 M
−88.95 M
−74.89%
2020
−118.79 M
−71.94 M
−153.57%
2019
−46.84 M
−23.05 M
−96.85%
Quarterly data
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−68.00 M
−51.00 M
−34.00 M
−17.00 M
0.00
Period
Value
Change
Change %
Q3 '24
−51.43 M
+13.72 M
+21.05%
Q2 '24
−65.15 M
+177.00 K
+0.27%
Q1 '24
−65.33 M
+2.60 M
+3.82%
Q4 '23
−67.92 M
−5.20 M
−8.30%
Q3 '23
−62.72 M
−4.37 M
−7.49%
Q2 '23
−58.35 M
+6.61 M
+10.17%
Q1 '23
−64.95 M
−13.20 M
−25.50%
Q4 '22
−51.75 M
+2.44 M
+4.50%